Abstract:Alzheimer’s disease (AD) is a complex heterogeneous neurodegenerative disease that requires an in-depth understanding of its progression pathways and contributing factors to develop effective risk stratification and prevention strategies. In this study, we proposed an outcome-oriented model to identify progression pathways from mild cognitive impairment (MCI) to AD using electronic health records (EHRs) from the OneFlorida+ Clinical Research Consortium. To achieve this, we employed the long short-term memory (LSTM) network to extract relevant information from the sequential records of each patient. The hierarchical agglomerative clustering was then applied to the learned representation to group patients based on their progression subtypes. Our approach identified multiple progression pathways, each of which represented distinct patterns of disease progression from MCI to AD. These pathways can serve as a valuable resource for researchers to understand the factors influencing AD progression and to develop personalized interventions to delay or prevent the onset of the disease.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis work was partially supported by a grant from the Ed and Ethel Moore Alzheimer's Disease Research Program of the Florida Department of Health (FL DOH #23A09) and grants (R01AG080624, R01AG080991, R01AG076234, and UL1TR001427) from the National Institutes of Health (NIH).### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study has been approved by the University of Florida Institutional Review Board (protocol no. IRB202202820).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes

Molecular Subtyping of Mild Cognitive Impairment Based on Genetic Polymorphism and Gene Expression

Classification and Interpretability of Mild Cognitive Impairment Based on Resting-State Functional Magnetic Resonance and Ensemble Learning.

Predicting Conversion from MCI to AD Combining Multi-Modality Data and Based on Molecular Subtype

Regional Radiomics Similarity Networks Reveal Distinct Subtypes and Abnormality Patterns in Mild Cognitive Impairment

Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer's disease using multimodal data

Definition and analysis of gray matter atrophy subtypes in mild cognitive impairment based on data-driven methods

Molecular Subtyping of Alzheimer's Disease Using RNA Sequencing Data Reveals Novel Mechanisms and Targets.

Topological Properties Analysis and Identification of Mild Cognitive Impairment Based on Individual Morphological Brain Network Connectome.

Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences

Delineating the Heterogeneity of Alzheimer's Disease and Mild Cognitive Impairment Using Normative Models of Dynamic Brain Functional Networks.

Machine Learning Detects Distinct Subtypes of Minimal Cognitive Impairment

Molecular subtyping of Alzheimer’s disease with consensus non-negative matrix factorization

Identification of Outcome-Oriented Progression Subtypes from Mild Cognitive Impairment to Alzheimer’s Disease Using Electronic Health Records

Discovering Alzheimer’s Disease Subtypes with Imaging and Genetic Signatures Via Multi‐view Weakly‐supervised Deep Clustering

Effect of PICALM Rs3851179 Polymorphism on the Default Mode Network Function in Mild Cognitive Impairment

Comparison of the neuropsychological characteristics of two subtypes of mild cognitive impairment

Association Study of Candidate Gene Polymorphisms with Amnestic Mild Cognitive Impairment in a Chinese Population

Decoding the Diagnostic Potential of T Cell Repertoires in Peripheral Blood of Patients from Amnestic Mild Cognitive Impairment to Alzheimer's Disease.

Evaluation of mild cognitive impairment genetic susceptibility risks in a Chinese population

Brain-Specific Gene Expression and Quantitative Traits Association Analysis for Mild Cognitive Impairment

Neuropsychological and Neuroimaging Characteristics of Amnestic Mild Cognitive Impairment Subtypes: A Selective Overview